Samuel Waxman Cancer Research Foundation logo

Samuel Waxman Cancer Research Foundation

NEW YORK, NY EIN: 13-3020943 Website

The Samuel Waxman Cancer Research Foundation (SWCRF) is a 501(c)(3) nonprofit organization dedicated to cancer research through collaborative, cross-institutional efforts. Based in New York, NY, the foundation operates as a research funding organization that supports scientists working to develop new cancer treatments. The organization was founded in 1976 and received its tax-exempt status in June 1983.

Financial Overview

From 2024 IRS Form 990-PF · View filing

Total Assets

$5.4M

-12.9% YoY

Annual Giving

$1.5M

-1.6% YoY

Grant Count

23

-4.2% YoY

Avg Grant Size

$64K

+2.7% YoY

Research compiled by Grantable AI from public sources. Last updated April 2026.

Mission & Focus Areas

The mission of SWCRF is to eradicate cancer by funding collaborative cross-institutional research to identify and correct abnormal gene function that causes cancer, with the goal of developing minimally toxic treatments for all patients with cancer.

The foundation's research approach centers on reprogramming cancer cells—altering cancer cells so they behave like normal, healthy cells. Scientists at SWCRF have demonstrated that this approach results in less toxic treatments that can cure cancer.

Key research initiatives include:

  • Aging and cancer research
  • Women's cancer research program
  • Cross-institutional collaborative research efforts

Grantmaking

SWCRF provides research funding opportunities and supports research lab costs. Recent grant activity includes:

Ready to take the next step with Samuel Waxman Cancer Research Foundation?

Geographic Focus

Where this funder awards grants

Grant Distribution by State

13states
+5 more states

Cities

BaltimoreBostonBronxCambridgeChapel HillChicagoCoral GablesDuranteFrederickGainesvilleGainsvilleHoustonLa JollaMemphisNew BrunswickNew YorkNovatoPhiladelphiaRedwood CitySan Francisco

Financial History

Multi-year comparison from IRS filings

As of Fiscal Year 2023:

  • Annual Revenue: $4.01 million
  • Annual Expenses: $4 million
  • Total Assets: $6.18 million
  • Total Liabilities: $310,000

As of Fiscal Year 2022:

  • Annual Revenue: $4.7 million
  • Total Assets: $6.1 million
  • Investments: $12,500

The organization maintains a 100% Four-Star rating based on its financial accountability and transparency.

Revenue
Expenses
Qualifying Distributions
Net Investment Income
$0$1M$3M$4M$6M20202021202220232024
Metric202420232022
Total Assets$5,376,278$6,175,563$6,125,031
Revenue$2,861,160$4,008,774$4,706,095
Expenses$3,737,329$4,004,625$2,897,746
Qualifying Distributions
Net Investment Income$26,337$10,259$3,501
Distributable Amount

Giving Over Time

Total grant dollars and number of grants per year

$0$376K$752K$1M$2M0 grants20200 grants202119 grants202224 grants202323 grants2024

Grant Insights

How this funder distributes its grants

Top Recipients

Top 10 recipients in 2024

Johns Hopkins University$163KThe General Hospital Cor…$125KIcahn School of Medicine…$125KMemorial Sloan Kettering$100KTrustees University of P…$100KStanford Univeristy$100KDana-Faber Cancer Instit…$100KCity of Hope$100KAlbert Einstein College …$80KBringham and Women's Hos…$75K

Grant Size Distribution

66 grants across all recorded years

42<$50K9$50–100K15$100–250K$250–500K$500K–1M$1–5M$5M+

Giving History

Grant recipients and amounts by year

No grants recorded for .

Leadership & Key People

Leadership team and compensation from IRS filings

Samuel Waxman — Founder and CEO

William Sullivan — Executive Director

Compensation Overview

From 2024 IRS filing

William T SullivanExecutive Director$328KSamuel Waxman MDDirector-CEO$220KGREGORY FABIJANCZUKCFO/DIRECTOR OF FINANCE$162KWylie TeneDirector of Marketing & Comm.$137KSuzanna C HoustonDirector of Special Projects$127KKAREN KIRKDIRECTOR OF SPECIAL EVENTS$115K

From 2024 filing

NameTitleHoursCompensation
William T SullivanExecutive Director50$327,600
Samuel Waxman MDDirector-CEO20$220,000
GREGORY FABIJANCZUKCFO/DIRECTOR OF FINANCE40$162,250
KAREN KIRKDIRECTOR OF SPECIAL EVENTS40$115,000
Wylie TeneDirector of Marketing & Comm.40$136,672
Suzanna C HoustonDirector of Special Projects40$127,233
Michael NierenbergChairman2
Spencer WaxmanPresident2
Dena K WeinerVice-President2
Thomas ConwayTreasurer2
Nicholas SantoroAssistant Treasurer2
Gerard J JoyceSecretary2
Christine ArlottaDirector1
Fredrick W BarneyDirector1
Ethan Dmitrovsky MDDirector1
Kenneth FishelDirector1
James FrankelDirector1
Dennis A HermanDirector1
Linda HermanDirector1
W David HinkelmanDirector1
James A IngramDirector1
Gary JacobDirector1
Matthew LyonsDirector1
Peeyush MisraDirector1
Gary NolanDirector1
Riva Ariella Ritvo-SlifkaDirector1
Lewis A RubinDirector1
Howard ShlafmitzDirector1
Baron SilversteinDirector1
Joseph SteffaDirector1
Marc TaubDirector1
Scott WaxmanDirector1
Ari ZagdanskiDirector1

Recent News & Activity

Recent developments and announcements

Multi-organization partnership announced $2.5 million for aging and cancer research

Multi-Organization Partnership Announces $2.5 Million for Aging and Cancer

Grantees selected for The Mark Foundation for Cancer Research and SWCRF Aging and Cancer Initiative

Multi-Organization Partnership Announces $2.5 Million for Aging and Cancer

The Mark Foundation for Cancer Research announced global expansion and $1 million funding boost for its flagship Emerging Leader Award

Multi-Organization Partnership Announces $2.5 Million for Aging and Cancer

Contact Information

Address: 420 Lexington Avenue, Suite 825, New York, NY 10170

Phone: 212-867-4502, 212-867-4851

Email: swcrf@waxmancancer.org

Website: waxmancancer.org

Related Funders

Similar funders by location and focus area

Data last updated April 2026. Sourced from IRS Form 990-PF filings. Research dossier generated April 2026.

What could you do with Samuel Waxman Cancer Research Foundation on Grantable?

  • Assess strategic fit with your organization
  • Draft a tailored letter of inquiry
  • Find open RFPs from this funder
  • Monitor for new funding opportunities